Clinical Trial Update: Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating autologous bone marrow mononuclear cell transplantation in stroke patients, sponsored by the National Cerebral a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Embolism
• Stroke

Drugs mentioned

• Autologous bone marrow mononuclear cell transplantation

Snippet

Sponsor: National Cerebral and Cardiovascular Center, Japan | Conditions: Cerebral Embolism, Stroke | Phase 1, Phase 2 | Status: COMPLETED